To evaluate the potential use of UBE2C and MGP as biomarkers for ESCC, we analyzed the protein levels of UBE2C and MGP in 205 training ESCC tumor tissues by immunohistochemistry (IHC). The gene discussed is UBE2C; the disease is esophageal squamous cell carcinoma.